The development of novel inhibitors of tumor necrosis factor-alpha production based on substituted [5,5]-bicyclic pyrozolones
Journal Article
·
· Bioorgan. Med. Chem.
OSTI ID:1008722
- PG
Novel substituted [5,5]-bicyclic pyrzazolones are presented as inhibitors of tumor necrosis factor-{alpha} (TNF-{alpha}) production. Many of these compounds show low nanomolar activity against lipopolysaccaride (LPS)-induced TNF-{alpha} production in THP-1 cells. This class of molecules was co-crystallized with mutated p38, and several analogs showed good oral bioavailability in the rat. Oral activity of these compounds in the rat iodoacetate model for osteoarthritis is discussed.
- Research Organization:
- Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 1008722
- Journal Information:
- Bioorgan. Med. Chem., Journal Name: Bioorgan. Med. Chem. Journal Issue: (16) ; 2004 Vol. 14; ISSN BMECEP; ISSN 0968-0896
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Substituted N-aryl-6-pyrimidinones: A new class of potent, selective, and orally active p38 MAP kinase inhibitors
5-Amino-pyrazoles as potent and selective p38[alpha] inhibitors
Phospholipase C-{delta}{sub 1} regulates interleukin-1{beta} and tumor necrosis factor-{alpha} mRNA expression
Journal Article
·
Mon Feb 27 23:00:00 EST 2012
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1026534
5-Amino-pyrazoles as potent and selective p38[alpha] inhibitors
Journal Article
·
Mon Feb 06 23:00:00 EST 2012
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1025635
Phospholipase C-{delta}{sub 1} regulates interleukin-1{beta} and tumor necrosis factor-{alpha} mRNA expression
Journal Article
·
Mon Oct 01 00:00:00 EDT 2012
· Experimental Cell Research
·
OSTI ID:22212601